肺炎慢性阻塞性肺病恶化的全身类固醇治疗:一项回顾性队列研究
Akihiro Shiroshita1,2,3,4, Keisuke Anan4,5, Masafumi Takeshita3
1Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
PloS one
|September 27, 2023
概括
对肺部慢性阻塞性肺病 (COPD) 恶化的全身类固醇治疗可能会增加30天的死亡率. 这项研究发现,在接受类固醇治疗的患者中,死亡风险更高,这表明在治疗这种疾病时要谨慎使用它们.
科学领域:
- 肺部病理学 肺部病理学
- 临床医学 临床医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 系统性类固醇在肺部慢性阻塞性肺病 (COPD) 恶化中的作用仍然不确定.
- 现有研究尚未确定类固醇治疗对这些患者死亡率的影响.
研究的目的:
- 为了评估系统性类固醇治疗和30天死亡率之间的关联,在患者住院治疗肺性COPD恶化.
- 为了调整已知的混因素,使用统计方法来澄清这种关系.
主要方法:
- 追溯分析来自日本医疗机构的数据,纵向跟踪患者.
- 纳入标准:因肺性COPD恶化而入院的40岁以上的患者,不包括特定病例.
- 用治疗权重和后勤回归的逆概率来分析主要结果:30天死亡率.
主要成果:
- 该研究包括3,662名肺性COPD恶化患者.
- 类固醇组的30天死亡率为27.6% (612名患者),非类固醇组的21.9% (3,050名患者).
- 系统性类固醇治疗与30天死亡率估计概率略高 (2.65%差异,p=0.181) 相关.
结论:
- 由于肺性COPD恶化,在入院后两天内开始的全身类固醇治疗可能与30天死亡率的增加有关.
- 需要进一步的研究,包括图表审查,以解决潜在的残留混因素.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
236
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
236
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.9K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.9K


